Caribou Biosciences (CRBU) Net Margin: 2020-2025
Historic Net Margin for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -1,337.58%.
- Caribou Biosciences' Net Margin rose 55165.00% to -1,337.58% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,708.08%, marking a year-over-year decrease of 26858.00%. This contributed to the annual value of -1,491.95% for FY2024, which is 119589.00% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Net Margin is -1,337.58%, which was up 25.02% from -1,783.95% recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Net Margin ranged from a high of -61.84% in Q3 2023 and a low of -1,893.87% during Q1 2024.
- Over the past 3 years, Caribou Biosciences' median Net Margin value was -1,337.58% (recorded in 2025), while the average stood at -1,339.44%.
- As far as peak fluctuations go, Caribou Biosciences' Net Margin surged by 77,209bps in 2021, and later slumped by 182,739bps in 2024.
- Quarterly analysis of 5 years shows Caribou Biosciences' Net Margin stood at -722.12% in 2021, then plummeted by 10,611bps to -828.22% in 2022, then crashed by 22,411bps to -1,052.33% in 2023, then plummeted by 81,936bps to -1,871.69% in 2024, then spiked by 55,165bps to -1,337.58% in 2025.
- Its Net Margin stands at -1,337.58% for Q3 2025, versus -1,783.95% for Q2 2025 and -1,823.76% for Q1 2025.